CHICAGO – The oral drug duo of sofosbuvir and ribavirin produced good cure rates in a study of 419 patients with hepatitis C genotype 2 or 3.
Dr. Bruce R. Bacon, who was not involved in the study,...
CHICAGO – An experimental triple-drug regimen with or without ribavirin cured more than 90% of 724 previously untreated patients with hepatitis C genotype 1 who did not have cirrhosis.
And it was...
BOSTON – Relaxing eligibility criteria for cytoreductive surgery may improve overall survival among patients with carcinoid metastases to the liver, investigators report.
Lowering the debulking...
CHICAGO – Medications to treat inflammatory bowel disease were well tolerated in pregnancy and weren’t linked to worse maternal-fetal outcomes, according to a study of more than 1,000 pregnant...
LAS VEGAS – Moderate intake of wine was associated with a 37% lower prevalence of chronic kidney disease in healthy adults, compared with no wine consumption at all, according to an analysis of data...
CHICAGO – Treating patients with hepatitis C virus genotype 1a or 1b with 12 weeks of an experimental interferon-free, triple-drug oral regimen produced good sustained virologic response rates with...
CHICAGO – Patients with hypothyroidism who needed higher doses of levothyroxine were more likely to have celiac disease, according to a study released at the annual Digestive Disease Week.
In a...
CHICAGO – A diet that restricts wheat, beans, dairy, and fruit juice in children with irritable bowel syndrome reduced the frequency and severity of abdominal pain, according to a study presented at...
CHICAGO – Oral sofosbuvir and ribavirin given for 12 weeks produced a sustained virologic response in 93% of 250 patients with hepatitis C virus genotype 2 and in 85% of patients with genotype 3...
CHICAGO – Esophageal dilation combined with standard medical management of eosinophilic esophagitis doesn’t provide added benefit over medication alone in terms of dysphagia relief, according to a...
